MERCK & CO, INC. for MERCK & CO INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to deferral of taxation of foreign earned income and corporate taxation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON BENJAMIN VAN PELT | — |
Copyright/Patent/Trademark CPT
Issues related to patent reform legislation (S. 515; HR 1260).
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURIE MICHEL | — |
Health Issues HCR
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA BLATTER | — |
| ERIN DARLING | — |
| ANNE ESPOSITO | — |
| JANE HORVATH | — |
| ELI JOSEPH | Leg. Ass't. White House Office of Leg. Affs. |
| LAURIE MICHEL | — |
| RAY QUINTERO | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ESPOSITO | — |
| JANE HORVATH | — |
| ELI JOSEPH | Leg. Asst. White House Off. of Leg. Affs. |
| LAURIE MICHEL | — |
| RAY QUINTERO | — |
| JASON BENJAMIN VAN PELT | — |
Budget/Appropriations BUD
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 10 Budget and L-HHS Appropriations bill). Issues related to seasonal and pandemic influenza funding (H.R. 2346; FY10 Labor-HHS Appropriations bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURIE MICHEL | — |
Medical/Disease Research/Clinical Labs MED
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ELI JOSEPH | Leg. Ass't. White House Off. of Leg. Affairs |
| LAURIE MICHEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.